You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Colitis, Lymphocytic

Showing 1 - 25 of 2,707
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systems Biology of Gastrointestinal and Related Diseases

Not yet recruiting
  • Ulcerative Colitis
  • +21 more
    • Bothell, Washington
      Viome Life Sciences
    Oct 10, 2022

    Lymphocytic Colitis, Diarrhea Trial in Rochester (Placebo, Budesonide)

    Terminated
    Has Results
    • Lymphocytic Colitis
    • Diarrhea
    • Rochester, Minnesota
      Mayo Clinic
    Oct 28, 2021

    Eosinophilic Colitis Trial (colonoscopy)

    Not yet recruiting
    • Eosinophilic Colitis
    • colonoscopy
    • (no location specified)
    Feb 9, 2023

    Microscopic Colitis Trial (Budesonide MMX®, Budesonide controlled ileal release (CR) capsules)

    Not yet recruiting
    • Microscopic Colitis
    • Budesonide MMX®
    • Budesonide controlled ileal release (CR) capsules
    • (no location specified)
    Jun 13, 2023

    Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

    Recruiting
    • Clinical Stage 0 Cutaneous Melanoma AJCC v8
    • +43 more
    • Best Practice
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Microscopic Colitis Clinical Scoring System in Chronic Watery

    Recruiting
    • Microscopic Colitis
      • Terrassa, Barcelona, Spain
        Hospital Universitari MútuaTerrassa
      Sep 1, 2023

      Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

      Terminated
      Has Results
      • Small Lymphocytic Leukemia (SLL)
      • Chronic Lymphocytic Leukemia (CLL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023

      Microscopic Colitis

      Recruiting
      • Colitis, Microscopic
        • Boston, Massachusetts
          Massachusetts General Hospital
        Aug 31, 2021

        Pathological Patterns in Chronic Diarrhea With Normal

        Not yet recruiting
        • Chronic Diarrhea
          • (no location specified)
          Mar 31, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

          Completed
          Has Results
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • La Jolla, California
          • +91 more
          Dec 14, 2021

          Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

          Active, not recruiting
          Has Results
          • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
          • Mantle Cell Lymphoma
          • Monterey, California
          • +4 more
          Aug 29, 2022

          Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)

          Active, not recruiting
          Has Results
          • Leukemia
          • +3 more
          • PCI 32765
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Dec 2, 2021

          Chronic Lymphocytic Leukemia Trial in Boston (IPI-145, Fludarabine, Cyclophosphamide)

          Active, not recruiting
          Has Results
          • Chronic Lymphocytic Leukemia
          • Boston, Massachusetts
          • +1 more
          Mar 10, 2022

          Risk Factors for Microscopic Colitis

          Completed
          • Colitis, Microscopic
            • Chapel Hill, North Carolina
              University of North Carolina
            Feb 19, 2021

            Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

            Active, not recruiting
            Has Results
            • Stage I Chronic Lymphocytic Leukemia
            • +3 more
            • Scottsdale, Arizona
            • +363 more
            Dec 30, 2022

            Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Idelalisib, Obinutuzumab)

            Completed
            Has Results
            • Chronic Lymphocytic Leukemia
            • Frankfurt, Brandenburg, Germany
            • +13 more
            Dec 24, 2021

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

            Active, not recruiting
            Has Results
            • Chronic Lymphocytic Leukemia
            • +3 more
            • Boston, Massachusetts
            • +11 more
            Nov 23, 2022

            Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)

            Active, not recruiting
            Has Results
            • Lymphocytic Leukemia, Chronic
            • Duarte, California
            • +136 more
            Dec 22, 2022

            Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

            Completed
            Has Results
            • Chronic Lymphocytic Leukemia
            • +2 more
            • ABT-199 (Main Cohort)
            • ABT-199 (Safety Expansion Cohort)
            • Tucson, Arizona
            • +47 more
            Nov 19, 2021

            Orelabrutinib in the Treatment of CLL/SLL

            Not yet recruiting
            • CLL/SLL
              • (no location specified)
              Jul 26, 2023

              Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

              Completed
              Has Results
              • Refractory Chronic Lymphocytic Leukemia
              • +4 more
              • Portland, Oregon
                OHSU Knight Cancer Institute
              Mar 15, 2021

              Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

              Completed
              Has Results
              • Follicular Lymphoma (FL/Indolent NHL)
              • +4 more
              • Huntsville, Alabama
              • +22 more
              Apr 1, 2022

              Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

              Completed
              Has Results
              • Chronic Lymphocytic Leukemia
              • Huntsville, Alabama
              • +87 more
              Apr 25, 2022

              Clinical Outcome of Treatment of Ulcerative Colitis in Adult

              Not yet recruiting
              • Ulcerative Colitis
                • (no location specified)
                Nov 20, 2023